Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (3y) (2012 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio Growth (3y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | -65.59% |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 4.33% |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 10.53% |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -66.89% |
| Dec 31, 2017 | -7.77% |
| Sep 30, 2017 | -4.55% |
| Jun 30, 2017 | 60.12% |
| Mar 31, 2017 | -141.73% |
| Dec 31, 2016 | -66.19% |
| Sep 30, 2016 | -39.24% |
| Jun 30, 2016 | -1.55% |
| Mar 31, 2016 | -8.73% |
| Dec 31, 2015 | 7.41% |
| Sep 30, 2015 | 1.58% |
| Jun 30, 2015 | -3.63% |
| Mar 31, 2015 | -11.75% |
| Dec 31, 2014 | 3.08% |
| Sep 30, 2014 | -37.43% |
| Jun 30, 2014 | 23.38% |
| Mar 31, 2014 | 12.36% |
| Dec 31, 2013 | 40.52% |
| Sep 30, 2013 | 95.38% |
| Jun 30, 2013 | 27.17% |